Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
MAPK/ERK Pathway
MAPK/ERK Pathway
/
Raf
Raf
Raf
Products (16)
CFT1946
CAS No.:
2882165-79-7
Sulindac sulfide
CAS No.:
49627-27-2
Dabrafenib
CAS No.:
1195765-45-7
Lonafarnib
CAS No.:
193275-84-2
Tovorafenib
CAS No.:
1096708-71-2
Osi-930
CAS No.:
728033-96-3
Dabrafenib Mesylate
CAS No.:
1195768-06-9
Agerafenib
CAS No.:
1188910-76-0
Bms-908662
CAS No.:
870603-16-0
Plx8394
CAS No.:
1393466-87-9
pan-RAF Inhibitor XP-102
CAS No.:
1392429-79-6
Brimarafenib
CAS No.:
1643326-82-2
Plx4032
CAS No.:
918505-61-0
Uplarafenib
CAS No.:
1425485-87-5
1-[5-Tert-butyl-2-(3-fluorophenyl)pyrazol-3-yl]-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea
CAS No.:
1777832-90-2
Dabrafenib
CAS No.:
1195765-45-7
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact